Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging of Sedation With Remimazolam

NCT07290205 is registered in ClinicalTrials.gov with Keith M Vogt as lead sponsor.

NCT NCT07290205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging of Sedation With Remimazolam
Lead sponsor
Keith M Vogt
Phase
Phase 1
Overall status
Recruiting
Start date
March 27, 2026
Completion date
December 2, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, pain, remimazolam